Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sharon Jiang
CREB3L1 as a Potential Biomarker Predicting Response of Triple Negative Breast Cancer to Doxorubicin-Based Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
PIM-1 Kinase: A Potential Biomarker of Triple-Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Neutrophil–lymphocyte Ratio Predicts Response to Chemotherapy in Triple-Negative Breast Cancer
Current Oncology
Oncology
Cholecalciferol-Peg Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer
AAPS PharmSciTech
Evolution
Ecology
Systematics
Crop Science
Aquatic Science
Behavior
Pharmaceutical Science
Medicine
Agronomy
Drug Discovery
Thymosin Beta 15A (TMSB15A) Is a Predictor of Chemotherapy Response in Triple-Negative Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells
British Journal of Cancer
Cancer Research
Oncology
CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Non-Platinum Metal Complexes as Potential Anti-Triple Negative Breast Cancer Agents
Crystals
Materials Science
Inorganic Chemistry
Chemical Engineering
Condensed Matter Physics
Triple-Negative Breast Cancer
Gene Expression Profiling Identified TP53MutPIK3CAWild as a Potential Biomarker for Patients With Triple‑negative Breast Cancer Treated With Immune Checkpoint Inhibitors
Oncology Letters
Cancer Research
Oncology
